Literature DB >> 10385319

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices.

T Sturniolo1, E Bono, J Ding, L Raddrizzani, O Tuereci, U Sahin, M Braxenthaler, F Gallazzi, M P Protti, F Sinigaglia, J Hammer.   

Abstract

Most pockets in the human leukocyte antigen-group DR (HLA-DR) groove are shaped by clusters of polymorphic residues and, thus, have distinct chemical and size characteristics in different HLA-DR alleles. Each HLA-DR pocket can be characterized by "pocket profiles," a quantitative representation of the interaction of all natural amino acid residues with a given pocket. In this report we demonstrate that pocket profiles are nearly independent of the remaining HLA-DR cleft. A small database of profiles was sufficient to generate a large number of HLA-DR matrices, representing the majority of human HLA-DR peptide-binding specificity. These virtual matrices were incorporated in software (TEPITOPE) capable of predicting promiscuous HLA class II ligands. This software, in combination with DNA microarray technology, has provided a new tool for the generation of comprehensive databases of candidate promiscuous T-cell epitopes in human disease tissues. First, DNA microarrays are used to reveal genes that are specifically expressed or upregulated in disease tissues. Second, the prediction software enables the scanning of these genes for promiscuous HLA-DR binding sites. In an example, we demonstrate that starting from nearly 20,000 genes, a database of candidate colon cancer-specific and promiscuous T-cell epitopes could be fully populated within a matter of days. Our approach has implications for the development of epitope-based vaccines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385319     DOI: 10.1038/9858

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  240 in total

1.  Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.

Authors:  O Schueler-Furman; Y Altuvia; A Sette; H Margalit
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

2.  Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach.

Authors:  J Zen; H R Treutlein; G B Rudy
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

3.  Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells.

Authors:  V Pancré; B Georges; G Angyalosi; F Castelli; A Delanoye; M Delacre; E Hachulla; B Maillere; A Bouzidi; C Auriault
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

4.  A novel predictive technique for the MHC class II peptide-binding interaction.

Authors:  Matthew N Davies; Clare E Sansom; Claude Beazley; David S Moss
Journal:  Mol Med       Date:  2003 Sep-Dec       Impact factor: 6.354

5.  Mapping of the immunodominant T cell epitopes of the protein topoisomerase I.

Authors:  S Veeraraghavan; E A Renzoni; H Jeal; M Jones; J Hammer; A U Wells; C M Black; K I Welsh; R M du Bois
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

6.  A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition.

Authors:  Zarixia Zavala-Ruiz; Iwona Strug; Bruce D Walker; Philip J Norris; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

7.  Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.

Authors:  Pedro A Reche; John-Paul Glutting; Hong Zhang; Ellis L Reinherz
Journal:  Immunogenetics       Date:  2004-09-03       Impact factor: 2.846

8.  Definition of supertypes for HLA molecules using clustering of specificity matrices.

Authors:  Ole Lund; Morten Nielsen; Can Kesmir; Anders Gorm Petersen; Claus Lundegaard; Peder Worning; Christina Sylvester-Hvid; Kasper Lamberth; Gustav Røder; Sune Justesen; Søren Buus; Søren Brunak
Journal:  Immunogenetics       Date:  2004-02-13       Impact factor: 2.846

9.  Predicting MHC-II binding affinity using multiple instance regression.

Authors:  Yasser EL-Manzalawy; Drena Dobbs; Vasant Honavar
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2011 Jul-Aug       Impact factor: 3.710

10.  HLA-DRB1-factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study.

Authors:  Christine L Kempton; Amanda B Payne
Journal:  Blood Adv       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.